Ankara Training and Research Hospital
Ankara, Altindag, 06230, Turkey (Türkiye)
NCT Number: NCT05340075
To determine the optimal time between the first and second operations in patients with bilateral kidney stones and scheduled percutaneous nephrolithotomy for the contralateral kidney. Patients who underwent percutaneous nephrolithotomy to the contralateral kidney 2-4 weeks and 4-6 weeks after the first operation will be compared.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Observational
Ankara, Altindag, 06230, Turkey (Türkiye)
The aim of the study is to determine the optimal time between the first and second operations in patients with bilateral kidney stones and scheduled percutaneous nephrolithotomy for the contralateral kidney. In our study, patients who underwent percutaneous nephrolithotomy to the contralateral kidney 2-4 weeks and 4-6 weeks after the first operation will be compared. With the guidance of preoperative and postoperative data, it is aimed to determine the optimal time with the lowest complication and highest operational success.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients who underwent percutaneous nephrolithotomy to the contralateral kidney 2-4 weeks and 4-6 weeks after the percutaneous nephrolithotomy operation
Time frame: 3 Months
BMI in kg/m^2
Time frame: 3 Months
rates of intraoperative blood transfusion, operation time(minute)
Time frame: 3 Months
mm size of the stone,
Ankara Training and Research Hospital
Other
Staged Bilateral Percutaneous Nephrolithotomy: When to Operate for a Contralateral Kidney?
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07445646
Calculi, Female Urogenital Diseases
Zagazig, Egypt
View Trial DetailsNCT04594161
Acute Kidney Injury, Bites and Stings
Amsterdam, North Holland, Netherlands
View Trial DetailsNCT05340088
Calculi, Female Urogenital Diseases
Ankara, Altindag, Turkey (Türkiye)
View Trial DetailsNCT05032287
Calculi, Female Urogenital Diseases
Al Mansurah, Aldakahlia, Egypt
View Trial Details